Trial Outcomes & Findings for Ischemic Preconditioning in Total Knee Arthroplasty (NCT NCT01333969)

NCT ID: NCT01333969

Last Updated: 2024-12-27

Results Overview

Visual Analogue Scale (VAS) are used to measure the intensity of pain. The total scale ranged from 0 (no pain) to 10 (excruciating pain). The average value at POD 48hours was reported for each arm/group.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

60 participants

Primary outcome timeframe

48hrs after surgery

Results posted on

2024-12-27

Participant Flow

Participant milestones

Participant milestones
Measure
Ishcemic Preconditioning
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Overall Study
STARTED
30
30
Overall Study
COMPLETED
30
30
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Ischemic Preconditioning in Total Knee Arthroplasty

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ishcemic Preconditioning
n=30 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=30 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Total
n=60 Participants
Total of all reporting groups
Age, Customized
Age
66.5 years
n=5 Participants
72.5 years
n=7 Participants
70.8 years
n=5 Participants
Sex: Female, Male
Female
19 Participants
n=5 Participants
14 Participants
n=7 Participants
33 Participants
n=5 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
16 Participants
n=7 Participants
27 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 48hrs after surgery

Visual Analogue Scale (VAS) are used to measure the intensity of pain. The total scale ranged from 0 (no pain) to 10 (excruciating pain). The average value at POD 48hours was reported for each arm/group.

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=30 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=30 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Postoperative Pain at Rest and Exercise as Assessed by Visual Analogue Scale (VAS) Scores at 48h After Surgery
VAS score at rest
1.75 score on a scale
Interval 0.02 to 2.25
.71 score on a scale
Interval 0.02 to 1.4
Postoperative Pain at Rest and Exercise as Assessed by Visual Analogue Scale (VAS) Scores at 48h After Surgery
VAS score with exercise
3 score on a scale
Interval 1.8 to 4.2
1.38 score on a scale
Interval 0.44 to 2.32

SECONDARY outcome

Timeframe: At 48hrs after surgery

Postoperative pain management included an epidural infusion of 10mcg/ml bupivacaine 0.06%/hydromorphone with a basal rate of 4 mL, a demand dose of 4 mL, and a lockout of 10 minutes. Basal rates were reduced to 2 mL and 0 mL in the morning of postoperative Days 1 and 2, respectively and epidural catheters removed on postoperative Day 2. Overall epidural volume was the total volume given over 48 hours.

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=30 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=30 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Overall Epidural Volume
140.5 mL
Standard Deviation 68.4
160.8 mL
Standard Deviation 70.1

SECONDARY outcome

Timeframe: At 48 hrs after surgery

muscle tissue oxygenation was measured using a novel noninvasive near infrared spectroscopy device at baseline and at 48 hours postoperatively

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=30 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=30 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Muscle Oxygenation Over Calf at 48h After Surgery
75 percentage of muscle tissue
Standard Deviation 22.4
69 percentage of muscle tissue
Standard Deviation 18.5

SECONDARY outcome

Timeframe: At 24 hours postoperatively

Population: IL-6 levels could not be measured for all patients.

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=24 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=28 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Levels of Interleukin 6 (IL6) in Drainage Fluid at 24hr Postoperatively
3.79 pg/ml
Interval 2.4 to 6.6
3.57 pg/ml
Interval 2.3 to 7.4

SECONDARY outcome

Timeframe: measured at 6 hours, 24 hours, and 48 hours

Periarticular circumference of the knee as compared to contralateral side as crude marker of swelling at 6h, 24, and 48h postoperatively. The data from the specified time points (6h, 24h, and 48h) were combined and the average value was reported for each arm/group.

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=30 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=30 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Periarticular Circumference of the Knee at 6h, 24h, and 48h
2.3 cm
Standard Deviation 3.2
1.5 cm
Standard Deviation 1.1

SECONDARY outcome

Timeframe: Up to discharge date

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=30 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=30 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Hospital Length of Stay
100.6 hours
Interval 56.2 to 145.0
99.4 hours
Interval 63.4 to 135.4

SECONDARY outcome

Timeframe: Up to discharge date

Amount of time until patients reached their physical therapy milestone (40 ft ambulation) during admission

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=30 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=30 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Physical Therapy Milestone
2.0 days
Interval 1.0 to 3.0
3.0 days
Interval 2.0 to 4.0

SECONDARY outcome

Timeframe: 24 hours postoperatively

Population: some patients were lost to follow up.

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=23 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=25 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Levels of Leukocytes in Drainage Fluid at 24hr Postoperatively
2487 cells/mm^3
Standard Deviation 2415.74
2038 cells/mm^3
Standard Deviation 1778.74

SECONDARY outcome

Timeframe: 24 hours postoperatively

Population: some patients were lost to follow up.

Outcome measures

Outcome measures
Measure
Ishcemic Preconditioning
n=28 Participants
In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). Ischemic Preconditioning: In the study group, the patients' operative limb will be preconditioned by inflating the tourniquet for 5 minutes, followed by deflation and a 5-minute reperfusion period. Subsequently, the tourniquet will be inflated for the entire length of the operation (before skin incision to after insertion of the final components). In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Control
n=29 Participants
In the control group, the tourniquet will be used for the entire length of the operation without a preconditioning phase.
Levels of TNF-alpha in Drainage Fluid at 24hr Postoperatively
3.72 pg/ml
Interval 3.09 to 4.65
3.76 pg/ml
Interval 3.05 to 5.82

Adverse Events

Ishcemic Preconditioning

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Stavros Memtsoudis

Hospital for Special Surgery

Phone: 646-797-8522

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place